WWMSC
ABBV icon

Wagner Wealth Management (South Carolina)’s AbbVie ABBV Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Buy
5,722
+186
+3% +$40K 0.27% 52
2026
Q1 		$1.2M Buy
5,536
+489
+10% +$108K 0.24% 53
2025
Q4 		$1.15M Buy
5,047
+586
+13% +$133K 0.25% 52
2025
Q3 		$1.03M Buy
4,461
+1
+0% +$204 0.24% 53
2025
Q2 		$828K Buy
4,460
+416
+10% +$77.3K 0.19% 60
2025
Q1 		$847K Buy
4,044
+14
+0.3% +$2.72K 0.21% 54
2024
Q4 		$716K Buy
4,030
+338
+9% +$62.1K 0.18% 59
2024
Q3 		$729K Sell
3,692
-108
-3% -$20.2K 0.2% 55
2024
Q2 		$652K Buy
3,800
+606
+19% +$100K 0.19% 59
2024
Q1 		$582K Sell
3,194
-3,562
-53% -$614K 0.18% 67
2023
Q4 		$1.05M Sell
6,756
-528
-7% -$77K 0.35% 49
2023
Q3 		$1.09M Buy
7,284
+337
+5% +$49.5K 0.4% 47
2023
Q2 		$936K Sell
6,947
-1,968
-22% -$289K 0.36% 52
2023
Q1 		$1.42M Sell
8,915
-1,547
-15% -$237K 0.65% 43
2022
Q4 		$1.69M Buy
10,462
+1,288
+14% +$197K 1.05% 27
2022
Q3 		$1.23M Sell
9,174
-224
-2% -$32.1K 0.91% 28
2022
Q2 		$1.44M Buy
9,398
+500
+6% +$76.4K 1.15% 24
2022
Q1 		$1.44M Sell
8,898
-4,851
-35% -$705K 1.01% 21
2021
Q4 		$1.86M Buy
13,749
+189
+1% +$22.3K 1.42% 16
2021
Q3 		$1.55M Sell
13,560
-589
-4% -$67.3K 1.24% 20
2021
Q2 		$1.59M Buy
14,149
+3,947
+39% +$445K 1.14% 20
2021
Q1 		$1.1M Buy
10,202
+1,905
+23% +$204K 0.87% 28
2020
Q4 		$889K Buy
+8,297
New +$797K 0.84% 36
2018
Q3 		$152K Buy
1,606
+1
+0.1% +$95 0.1% 153
2018
Q2 		$149K Buy
1,605
+38
+2% +$3.71K 0.11% 139
2018
Q1 		$148K Buy
1,567
+16
+1% +$1.76K 0.11% 133
2017
Q4 		$154K Buy
+1,551
New +$146K 0.12% 134

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s ABBV Position: Q2 2026 in Review

Wagner Wealth Management (South Carolina) increased its AbbVie (ABBV) stake by 3.4% in Q2 2026, buying an estimated $40K and bringing the position to 5,722 shares worth $1.44M. The position accounts for 0.27% of the portfolio, ranked #52.

Wagner Wealth Management (South Carolina) first reported a position in ABBV in Q4 2017 and has held it in 27 quarters since. The position peaked at $1.86M in Q4 2021. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wagner Wealth Management (South Carolina) held 5,722 shares of AbbVie worth $1.44M as of Q2 2026.
  • Wagner Wealth Management (South Carolina) bought 186 AbbVie shares in Q2 2026, an estimated $40K.
  • AbbVie made up 0.27% of Wagner Wealth Management (South Carolina)'s portfolio in Q2 2026, its #52 holding.
  • Wagner Wealth Management (South Carolina) first reported a position in AbbVie in Q4 2017 and has held it in 27 quarters since.
  • Wagner Wealth Management (South Carolina)'s AbbVie position peaked at $1.86M in Q4 2021.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q2 2026, filed 24 Jul 2026.